The bovine herpesvirus type 1 (BHV-1) protein VP8 is present, in large amounts, in the tegument of virions. As a preliminary step towards determining the function of VP8 and the biological relevance for its abundant presence, we describe the mapping of the location of its gene and determination of its nucleotide sequence. The gene for VP8 was located between 0.088 and 0.108 map units on the BHV-1 genome and contained a 2226 bp reading frame encoding a 742 amino acid protein.
Introduction
Virions of bovine herpesvirus type 1 (BHV-1) comprise about 25 to 33 polypeptides (Pastoret et al., 1980; Misra et al., 1981) . Cells infected with the virus contain an additional 15 polypeptides that are not represented in purified virions (Misra et al., 1981) . The nucleotide sequences of the genes for some of these polypeptides have been determined. These include BHV glycoprotein B or gI (Misra et al., 1988; Whitbeck et al., 1988) , BHVgC or glII (Fitzpatrick et al., 1989) , BHV-gD or glV (Tikoo et al., 1990) and thymidine kinase (TK) (Mittal & Field, 1989; Smith et al., 1990) . The location on the genome of other viral genes, including those for the DNA polymerase (Owen & Field, 1988 ) and the major DNA-binding protein (Bandyopadhyay et al., 1990) , have also been mapped.
As with other herpesviruses the expression of BHV-1 genes is temporally regulated such that viral proteins can be categorized as immediate early (0t), early (fl) or late (J depending upon the order of their synthesis in the infected cell (Misra et al., 1981 ; Ludwig & Letchworth, 1987; Nelson et al., 1989) . The ~, gene products can be divided further into 71 and 72 subclasses. The ~,1 genes are expressed earlier in infection than 72 genes and are affected minimally if viral DNA replication is interrupted. The ~2 genes are expressed later in infection and are not expressed if viral DNA synthesis is blocked.
Virions of BHV-1 contain an abundance of a protein that has been designated VP8 (Misra et al., 1981) , VP7 (Pastoret et al., 1980) or 107K (Marshall et al., 1986) . The protein, which is also the most abundant viral protein in infected cells, has been shown to be located in the tegument of virions (Marshall et al., 1986) and preliminary results (G. Weinmaster, unpublished results) suggest that it is a 7 phosphoprotein.
In this communication, as the first step towards determining the function of VP8 and the biological relevance for its abundant presence, we describe the mapping of the location of its gene and the determination of its nucleotide sequence. The amino acid sequence of VP8 bears considerable resemblance to that of the herpes simplex virus type 1 (HSV-1) gene UL47.
Methods
Cells and virus. BHV-1 strain P8-2 was isolated at the University of Wisconsin by J. R. Saunders. Details of virus propagation in MadinDarby bovine kidney (MDBK) cells have been published (Misra et aL, 1981) . To obtain radiolabelled infected cell proteins, cells infected with BHV-I at a multiplicity of infection of 10 p.f.u, per cell were maintained in either methionine-free medium to which [35Slmethion-ine (100~tCi/ml) had been added or in phosphate-free medium supplemented with 500 ~tCi of H332po4 per ml. Cells were harvested 20 h after infection.
Construction of a 2gtl l expression library. BHV-I genomic DNA (2.5 ~tg) was partially digested with the restriction enzymes HaelII (2.5 units) and RsaI (7 units) for 8 min. The digest was electrophoresed through a 0.8~ agarose gel and DNA fragments, 500 to 2000 bp in length, were eluted from the gel. EcoRI linkers (Promega) were ligated to the fragments, which were then digested with EcoRI. The fragments were cloned into Protoclone 2gt 11 arms (Promega) and packaged using the Packagene in vitro packaging system (Promega). The library was grown on Escherichia coli host strain Y1090(r-) and expression of the pgalactosidase-VP8 fusion protein was induced with isopropyl thio-fl-l> galactoside (Bethesda Research Laboratories). Plaques were transferred to nylon membranes by the method of Maniatis et aL (1982) .
VP8polyclonal antisera. Antisera to VP8 were raised in rabbits. The polypeptides of virions purified from infected ceils in eight t00 mm diameter culture plates were separated by electrophoresis through a preparative 7-5% (w/v) SDS-PAGE gel (Misra et al., 1981) . The outer lanes of the gel were stained with Coomassie blue to visualize the proteins. The segment of the unstained gel, which corresponded to the VP8 band, was excised and dialysed in water to remove SDS. The gel slices were homogenized to a slurry with a Polytron homogenizer (Brinkman Instruments). Freund's complete adjuvant (1 ml) and the slurry (1 ml) were mixed and 0-4 ml inoculant was injected intramuscularly and subcutaneously at several sites. At 2 week intervals, 1 ml slurry and 1 ml Freund's incomplete adjuvant were mixed and injected into the rabbits. Eight weeks after the initial immunization, the rabbits were bled and serum was collected. The rabbit serum was absorbed with ProtoBlot E. coli extract (Promega) to remove cross-reacting antibodies. The resulting serum, diluted 1 : 500, was used to detect VP8-expressing plaques from the 2gtl I library. Bound antibody was visualized with horseradish peroxidase-labelled anti-rabbit antibody (Bio-Rad).
Mapping of the VP8 gene on the BHV-1 viral genome. Viral genomic DNA (2 rtg) was digested with the restriction enzymes EcoRI, HpaI, HindlII and BgllI (5 units, 1 h at 37 °C) then electrophoresed through a 0.8% agarose gel. The DNA fragments were transferred to a nylon membrane (Amersham) and hybridized to a radiolabelled DNA fragment isolated from the 2gtl 1 clone that reacted with the anti-VP8 serum.
S~ nuclease mapping of the start of transcription.
A variation of the procedure of Berk & Sharp (1977) was used to map the start of transcription of the VP8 gene. The VP8 gene was mapped, by Sl nuclease digestion, in two segments. The 3-0 kb EcoRl G fragment (Fig. 2) was cloned into the EcoRI site of the multiple cloning site of pEMBL18. The orientation of the insertion was determined from the location of an internal HindlII site. A HindlII digest would excise a 2-0 kb fragment if the insert was cloned in one direction or a 1.0 kb fragment if it was cloned in the other direction. A clone that released a 2.0 kb fragment upon HindlII digestion was digested with ApaI and HindlIl. A 1300 bp ApaI-EcoRI fragment of BHV-1 DNA, with the entire multiple c!oning site adjacent to the EcoRI end, was eluted from the gel and was labelled at the 5' ends with [y-32p]ATP using alkaline phosphatase (Promega). The fragment was then digested with EcoRI to remove the labelled multiple cloning site. The result was a 1300 bp EcoRI-ApaI fragment labelled on one strand at the ApaI site. A similar strategy was used to label the 1700 bp EcoRI-HindIII portion of the 3-7 kb HindlIl M fragment. The entire 3-7 kb HindlII M fragment was cloned into the HindlIP site of the multiple cloning site. An internal EcoRI restriction site was used to determine the orientation. The 1700 bp EcoRI-HindlII portion with the entire multiple cloning site at the HindlII end was released with an EcoRI digest. This was eluted from a gel, labelled and the multiple cloning site was removed with a HindIII digest. This resulted in a 1700 bp EcoRI-HindlII fragment labelled 5" on one strand at the EcoRI site. Labelled DNA was hybridized to total infected cell RNA at a ratio of 1:5. Total infected cell RNA was isolated from MDBK cells, by the method of Cathala et al. (1983) , 20 h after BHV-I infection. Products of S~ digestion were electrophoresed on a urea-containing 6% (w/v) acrylamide gel. A ~2Pqabelled BstEII digest of 2 DNA was denatured and electrophoresed to determine the size of the fragments protected from digestion with $1 nuclease.
In vitro transcription and translation. The coding sequence for the VP8 gene was cloned between the AccI and HindllI sites of pGEM-3Z (Promega) in a two step cloning reaction. First the HindlIl M fragment was cloned into the HindlII site of pGEM-3Z. An EcoRI digest was used to determine the fragment orientation. A clone that would release a 1.7 kb fragment upon EcoRI digestion was isolated. This clone was digested with Accl which released a 600 bp fragment and a 1100 bp fragment from the vector which still contains 2000 bp of the VP8 gene. The 1100 bp fragment and the pGEM-partial VP8 fragment were eluted from a gel and ligated. Regeneration of the VP8 gene coding sequence in the pGEM vector was screened by EcoRI digestion. RNA was transcribed from the T7 promoter using the Riboprobe system (Promega). During transcription the transcripts were capped with the cap analogue pGppp (Pharmacia). The capped RNA was translated in a rabbit reticulocyte lysate containing PSlmethionine (Pelham & Jackson, 1976) . The reticulocyte lysate was a gift from A. J. Pawson (Univeristy of Toronto).
Immunoprecipitation. Immunoprecipitations were carried out using the method of Misra et al. (1982) using monclonal antibodies (MAbs) or polyclonal antisera developed in our laboratory.
Sequencing. Sequenase and 7-deaza-dGTP reagents (United States Biochemicals) were used to determine the nucleotide sequence of the VP8 gene. Nested deletions of the DNA or subclones, constructed using convenient restriction sites, were used to sequence both strands of the entire VP8 coding region. Regions downstream from the VP8 coding region were sequenced on one strand only.
Protein sequence alignment. VP8 and UL47 protein sequences were aligned using the CLUSTAL computer program of Higgins & Sharp (1988) .
Results

VP8 is a y2 phosphoprotein
The protein we have designated VP8 (Misra et al., 1981) is made in the later stages of infection and is the most abundant of the virion proteins of BHV-1 (Misra et al., 1981; Pastoret et al., 1980; Marshall et al., 1986) . VP8 has also been shown to reside in the viral tegument (Marshall et al., 1986) and G. Weinmaster (unpublished results) demonstrated that BHV-l-infected cells contain a phosphoprotein with an electrophoretic mobility similar to that of VP8.
To confirm that VP8 is a 7 class phosphoprotein, BHV-1 infected cells were labelled with either [35S]methionine or H332po4, in the presence or absence of 250 ~tg phosphonoformic acid (PFA) per ml medium. VP8 and BHV-gB, afl class protein (Nelson et al., 1989) , were then immunoprecipitated from the cell lysates. Monoclonal antibodies were used for immunoprecipitation. Fig. 1 shows that although 35S-labelled intact BHV-gB (130K) and its cleavage products (70K and 50K) were immunoprecipitated from PFA-treated and untreated cells, VP8 and 60K proteolytic degradation product were immunoprecipitated only from cells in which viral DNA synthesis had not been interrupted by PFA. VP8, immunoprecipitated from untreated infected cells, was labelled with 32p. These results confirm that VP8 is a y2 class phosphoprotein. 
Screening the 2gt11 library
A BHV-1 expression library was constructed to isolate a DNA probe for the VP8 gene. To determine which phage in the expression library contained a portion of the VP8 gene, polyclonal antisera to the protein were raised in rabbits. Serum from rabbits, immunized three times with VP8 protein, bound to the VP8 protein in Western blot analysis. The VP8 antiserum detected a plaque from the 2gtl 1 BHV-1 genomic library. This clone contained a 600 bp fragment of BHV-1 DNA. The 5' end of this fragment was sequenced using a primer homologous to the coding sequences of fl-galactosidase in 2gtll to determine in which reading frame this fragment was being expressed.
Mapping the location of VP8 on the BHV-1 genome
The 600 bp DNA fragment from the expression library was used to probe fragments in EcoRI, HpaI, BglII and HindIII digests of the BHV-1 genome. The location of the sites for these enzymes onthe P8-2 strain of the BHV-1 genome have been mapped (M. A. N. Beckie, unpublished results). The probe hybridized to the 3 kb EcoRI G fragment (0-096 to 0.119 map units), the 15 kb HpaI D fragment (0.032 to 0-143 map units), the 3.7 kb HindIII M fragment (0.083 to 0-111 map units) and the 12-5 kb BglII E fragment (0.026 to 0.119 map units). These fragments all map at the left-hand end of the BHV-1 genome (Fig. 2) .
$1 nuclease mapping the VP8 transcriptional start site
The transcriptional start site of the VP8 gene was located on the 3.7 kb HindlII M fragment by $1 nuclease mapping. The HindlII M fragment was digested into a 1300 bp ApaI-EcoRI fragment and a ! 700 bp EcoRI- HindlII fragment (Fig. 3c) . RNA from BHV-l-infected cells protected the entire 1300 bp ApaI-EcoRI portion of the 3-7 kb HindlII fragment from $1 digestion (Fig. 3a) suggesting that the fragment was included, in its entirety, within a transcript. The size of the 1700 bp EcoRIHindlII subfragment, labelled with 32p at the EcoRI site, was reduced in size by 600 bp by $1 nuclease, indicating that the beginning of the main transcriptional unit in this fragment was about 1100 bp from the EcoRI site (Fig.  3 b) . A minor transcription start site mapped about 650 bp from the EcoRI site.
Immunoprecipitation
To confirm that the transcription start site, identified by the $1 protection experiments, was that of VP8, a 3.1 kb
AccI-HindlII piece of DNA from the HindlII M fragment was cloned between the AccI and HindIII sites of pGEM-3Z. The AccI site in the HindlII M fragment was located immediately upstream from the putative start site of the VP8 transcript (Fig. 3c) . In vitro transcription, from the T7 promoter of pGEM-3Z, resulted in a single 3.1 kb RNA transcript. In vitro translation of this RNA produced a 90K protein which could be immunoprecipitated from the reticulocyte lysate by the anti-VP8 sera used initially to screen the 2gtl 1 BHV-1 genomic library but not with monoclonal antibodies to BHV-gB (Fig. 4) 
Sequencing
After confirming that the DNA from the HindlII M fragment contained the gene for VP8, the nucleotide sequence of both strands of the fragment from the AccI site to 2500 bp downstream was determined (Fig. 5) 
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Discussion
Several lines of evidence suggest that the BHV-1 protein VP8 is a homologue of the product of the HSV-1 gene UL47. First, the genomic map location of VP8 is similar to UL47 with respect to other shared homologues, (e.g. gB, gC, DNA polymerase, TK and capsid protein) of the viruses (Fig. 7) . Varicella-zoster virus (VZV) also has a gene arrangement collinear to those of BHV-1 and HSV-1, with the open reading frame 11 mapping in the same relative location as VP8 and UL47 (Wirth et al., 1989; McGeoch et al., 1988; Davison & Scott, 1986) . Additional evidence is found in RNA transcript mapping. UL47 is transcribed as a 4.7 kb ),2 transcript which shares a 3' terminus with a 2.5 kb 71 transcript (Hall et al., 1982) . This is very similar to the transcript map of the corresponding region of the BHV-1 genome. Wirth et al 0989) showed that the 3-7 kb HindlII M fragment hybridizes to a 4-5 kb ~2 and a 2-7 kb 71 transcript. In Northern blot analysis, we have found the 1300 bp ApaI-EcoRI fragment, containing the distal half of the VP8 gene, hybridized to a 4.5 kb transcript (data not shown) of which only the first 2700 bp would encode the VP8 protein. Immediately downstream from the VP8 coding sequence there is a promoter consensus sequence (Fig. 5) which may be the regulatory sequence for the transcript that shares a 3' terminus with VP8.
Finally, we have sequenced the BHV-1 VP8 gene and shown that the derived amino acid sequence has considerable homology to the derived amino acid sequence of HSV-1 UL47 (McGeoch et al., 1988) . Blocks of identical amino acids appear throughout the sequences; however, the carboxy half of the molecules appear to have maintained greater conservation. The proteins differ in size by 49 amino acids. This size difference generally seems to be due to changes in the amino terminal half of the proteins. VP8 also shares considerable homology with VZV open reading frame 11. Once again there seems to be more conservation of the carboxy half of the proteins with variability in the amino half of the molecule.
In HSV-l-infected cells, viral gene expression is initiated when the major structural tegument protein Vmw65 (~-trans-inducing factor or g-TIF) forms a complex with cellular proteins which then bind to cisacting elements in the g gene promoters (Roizman et al., 1988) . A review of Vmw65 interaction with cellular proteins is presented by Stern et al. (1989) and Goding & O'Hare (1989) .
The gene products of the HSV-1 open reading frames UL47 and UL46 were initially implicated as modulators of the ~-TIF trans-activation in transient expression systems (McKnight et al., 1987) . A more recent paper indicates that deletion of UL46, within the context of the virus, has no apparent effect on ~-TIF trans-activation but deletion of UL47 has a significant effect (Zhang et al., 1991) . It is not known by what mechanism the product of UL47 affects ~-TIF trans-activation. The coding sequence for UL47 is reportedly not required for viral replication in cell culture (Barker & Roizman, 1990; Zhang et al., 1991) .
Previous research demonstrates that VP8 protein is located in the tegument of BHV-1. Bolton et al. (1983) showed that if BHV-1 virions are disrupted with the detergent NP40, approximately half of the VP8 protein fractionates with the membranes and the other half fractionates with the nucleocapsids. Marshall et al. (1986) confirmed these results with similar experiments but also iodinated the surface proteins of BHV-1 virions. Unlike the glycoproteins, VP8 is not iodinated on intact infected cells but can be iodinated after viral disruption with NP40.
Although there is little published data on BHV-1 gene regulation suggesting that it is identical to HSV-1 gene regulation, we find it useful to base hypotheses on systems which, at least initially, appear to be similar. The identification of VP8 as the major tegument protein of BHV-1 and demonstration that it is homologous to the HSV-1 UL47 gene product is consistent with the identification of the HSV-1 UL47 gene product as a major tegument protein of HSV-l virions (McLean et al., 1990) . Upon viral infection, UL47, a modulator of g-TIF, as well as the a-TIF is carried into the cell. U'L47 may act by complexing with the g-TIF and cellular proteins or by modifying g-TIF or cellular proteins, changing their ability to trans-activate immediate early genes. It has been known for some time that HSV-I carries a protein kinase in its tegument (Lemaster & Roizman, 1980) . It is possible UL47 may have kinase activity that modulates the activity of the phosphoprotein Vmw65 (~-TIF). We have recently shown that BHV-1 carries protein kinase activity in its tegument. Initial results suggest this kinase activity may be attributed to the VP8 protein and we are investigating this possibility futher.
